Skip to main content
Log in

IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of the study was to investigate the association between IL-8 and other biomarkers of endothelial dysfunction (MCP-1, V-CAM, I-CAM) and the disease activity scores in a sample of 54 patients with ankylosing spondylitis (AS) without use of biological agents. Fifty-four AS patients without treatment with anti-TNFs agents between 18 and 80 years old, who met modified New York criteria and at the same time the axial ASAS criteria, were evaluated using an epidemiological questionnaire that included among others clinical data, BASDAI, BASFI, ASQoL, ASDAS and plasma levels of CRP, ESR, MCP-1, IL-8, ICAM-1 and VCAM-1. IL-8 varied in proportion to disease activity rates (BASDAI and ASDAS) p < 0.05, being strongly correlated with the disease activity. The levels of adhesion molecules I-CAM and VCAM, as described in other studies, were positively correlated with predisposing factors for cardiovascular disease. IL-8 has shown to be strongly correlated with clinical markers of disease activity and inflammatory activity and may be an additional variable to the overall assessment of the activity of the AS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dougados M (1995) Diagnostic features of ankylosing spondylitis. Br J Rheumatol 34:301–305

    Article  PubMed  CAS  Google Scholar 

  2. Van Der Linden S, Van Der Heijde D (1998) Ankylosing spondylitis: clinical features. Rheum Dis Clin North Am 24(4):663–676

    Article  PubMed  Google Scholar 

  3. Sampaio-Barros P, Azevedo VF, Bonfiglioli R, Campos WR, Carneiro SCS, Carvalho MAP et al (2007) Consenso brasileiro de espondiloartropatias: espondilite anquilosante e artrite psoriásica diagnóstico e tratamento—primeira revisão. Rev Bras Reumatol 47(4):233–242

    Article  Google Scholar 

  4. Peters MJ, van der Horst-Bruinsma IE et al (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585–592

    Article  PubMed  Google Scholar 

  5. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167–2172

    PubMed  Google Scholar 

  6. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449

    Article  PubMed  CAS  Google Scholar 

  7. Onat A, Direskeneli H (2012) Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapy. Curr Pharm Des 18(11):1465–1477

    Article  PubMed  CAS  Google Scholar 

  8. Kang JH, Chen YH, Lin HC (2010) Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 69(6):1165–1168 (Epub 2010 Apr 7)

    Article  PubMed  Google Scholar 

  9. Joven J, Rubiés-Prat J, Ras MR, de la Figuera M, Lience E, Masdeu S (1984) High density lipoprotein cholesterol subfractions and apoprotein A-I in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 27(10):1199–1200

    Article  PubMed  CAS  Google Scholar 

  10. Azevedo VF, Pecoits-Filho R (2010) Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int 30(11):1411–1416

    Article  PubMed  CAS  Google Scholar 

  11. Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49(9):1618–1631 (Epub 2010 Mar 24)

    Article  CAS  Google Scholar 

  12. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD (2011) Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 31(2):153–164

    Article  PubMed  CAS  Google Scholar 

  13. Maksimowicz-McKinnon K, Bhatt DL, Calabrese LH (2004) Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers. Curr Opin Rheumatol 16(1):18–24

    Article  PubMed  CAS  Google Scholar 

  14. Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28(2–3):69–75

    Article  PubMed  CAS  Google Scholar 

  15. Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ (1994) Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75(1):1–7

    Google Scholar 

  16. Apostolakis S, Papadakis EG, Krambovitis E, Spandidos DA (2006) Chemokines in vascular pathology. Int J Mol Med 17:691–701

    PubMed  CAS  Google Scholar 

  17. Baggiolini M, Clark-Lewis I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307(1):97–101

    Article  PubMed  CAS  Google Scholar 

  18. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA et al (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718–723

    Article  PubMed  CAS  Google Scholar 

  19. Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL et al (1994) Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75:1–7

    Article  PubMed  CAS  Google Scholar 

  20. O’Hayre M, Salanga CL, Handel TM, Allen SJ (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409:635–649

    Article  PubMed  Google Scholar 

  21. Conti P, DiGioacchino M (2001) MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 22:133–137

    Article  PubMed  CAS  Google Scholar 

  22. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  PubMed  Google Scholar 

  23. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of Spondylarthritis international Society classification criteria for axial spondylarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783 (Epub 2009 Mar 17)

    Article  PubMed  CAS  Google Scholar 

  24. Taylor PC, PetersAM Paleolog E, ChapmanPT Elliott MJ, McCloskey R et al (2000) Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthrit Rheum 43:38–47

    Article  CAS  Google Scholar 

  25. Limón-Camacho L, Vargas-Rojas MI, Vázquez-Mellado J, Casasola-Vargas J, Moctezuma JF, Burgos-Vargas R, Llorente L (2012) In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis. J Rheumatol 39(4):830–835

    Google Scholar 

  26. Azuz-Lieberman N et al (2005) The involvement of NK cells in ankylosing spondylitis. Int Immunol 17(7):837–845

    Article  PubMed  CAS  Google Scholar 

  27. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study. Circulation 96:4219–4225

    Article  PubMed  CAS  Google Scholar 

  28. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L et al (2001) Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358:971–976

    Article  PubMed  CAS  Google Scholar 

  29. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, Mekori YA et al (2002) Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the bezafibrate infarction prevention (BIP) Study. J Am Coll Cardiol 39:1133–1138

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valderilio Feijó Azevedo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azevedo, V.F., Faria-Neto, J.R., Stinghen, A. et al. IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents. Rheumatol Int 33, 1779–1783 (2013). https://doi.org/10.1007/s00296-012-2631-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2631-x

Keywords

Navigation